Stockreport

Anika Therapeutics Touts $3B TAM, Cingal & Hyalofast Growth Plans at Canaccord MSK Conference [Yahoo! Finance]

Anika Therapeutics Inc.  (ANIK) 
Last anika therapeutics inc. earnings: 2/20 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.anikatherapeutics.com/investor-relations
PDF operating cash flow), with more than $50M in cash and no debt supporting its balance sheet. Management frames a $3 billion TAM led by $1B opportunities for Hyalofast [Read more]